To ask whether macrophage function from cHL patients is regulated by A20 through mTOR signaling, cells were treated with Dox in combination with mTOR signaling inhibitor Everolimus with or without of A20 siRNA. This evidence concerns the gene MTOR and classic Hodgkin lymphoma.